stock

Divi’s Laboratories reported a 64.5% increase in its Q3 net profit, reaching ₹589 crore, while revenue grew by 25%.

by

Divi’s Laboratories, a leading active pharmaceutical ingredients (API) manufacturer, reported a 64.52% rise in its consolidated profit after tax (PAT) for the quarter ending December 2024, reaching ₹589 crore, up from ₹358 crore in the same period last year, according to the company’s exchange filing. Revenue from operations for Q3 FY25 surged by 25% to … Read more

SENSEX and NIFTY50 drop by up to 1%: Trump’s tariff and other key factors trigger fresh market sell-off.

by

The domestic equity market opened with significant losses on Monday, February 3, following the downward trend seen in Asian markets, as investors remained cautious amid weak global cues. The imposition of 25% tariffs on most imports from Canada and Mexico, along with 10% tariffs on goods from China, triggered concerns across global markets, leading to … Read more